Multifunctional
Ca2+/calmodulin-dependent protein kinase (CaM kinase) participates in diverse calcium signaling pathways in neurons.
The (Y-and p-CaM kinase isoforms are neuron-specific and highly abundant in rat brain. The variable domain of CaM kinase is a potential site for the generation of isoform diversity by alternative spicing of its N-and/or C-terminal segments. We used specific PCR primers which span the variable domain of either (Y-or p-CaM kinase and isolated three new isoforms from rat brain, namely CX~-, p,-and S',-CaM kinase. cw,-CaM kinase contains 11 amino acids, likely inserted by alternative splicing, at the C-terminal segment of the variable domain. This insertion introduces a nuclear localization signal (NLS) that targets ar,-CaM kinase to the nucleus of transfected cells; a-CaM kinase is excluded from the nucleus. The mRNA and the protein corresponding to this isoform are detected only in the diencephalon/midbrain regions. We have also identified two alternatively spliced isoforms of P-CaM kinase that lack the 24 amino acid sequence at the N-terminal segment of the variable domain. Alternative splicing of these two isoforms occurs with a three base pair shift of the 3'-splice site. Our analysis shows that these new p-CaM kinase isoforms are expressed primarily in early developmental stages, and we therefore term them p. -(embryonic) and p',-CaM kinase. Recombinant (Ye-, p,-and p',-CaM kinase expressed in COS-7 cells exhibit characteristic Ca2+/calmodulin-dependent protein kinase activity and autophosphorylation.
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Multifunctional Ca*+/calmodulin-dependent protein kinase (CaM kinase or CaM kinase II) is a major mediator of calcium signaling in neurons. Increases in the intracellular concentration of calcium lead to the activation of the kinase which in turn phosphorylates multiple substrates on serine/threonine residues. CaM kinase is involved in diverse functions in neurons, including neurotransmitter synthesis and neurotransmitter release, modulation of ion channels activity, synaptic plasticity, and gene expression (reviewed in Hanson and Schulman, 1992a; Braun and Schulman, 1995) . The kinase has been localized to both the presynaptic and the postsynaptic compartments of neurons. In adult brain, about 75% of CaM kinase activity is associated with cytoskeletal elements, postsynaptic densities (PSD), and synaptic vesicles, and the remaining activity is cytosolic (reviewed in Rostas and Dunkley, 1992) .
The diversity in the function and the subcellular localization of CaM kinase suggests a structural heterogeneity of the enzyme. Structural complexity arises in part from the expression of CaM kinase from four distinct genes--a, B, y, and 6 (Bennett and Kennedy, 1987; Hanley et al., 1987; Lin et al., 1987; Tobimatsu et al., 1988; Tobimatsu and Fujisawa, 1989) . All the isoforms share a domain structure consisting of a catalytic domain at the N-terminal half followed by a regulatory domain which contains an autoinhibitory segment overlapping a calmodulin binding site. The C-terminal part of the protein is called the association domain and is thought to be involved in the oligomerization of CaM kinase isoforms to a holoenzyme (Lin et al., 1987; Yamauchi et al., 1989) .
The least conserved region across CaM kinase sequences is at the border of the regulatory and association domains, termed the variable domain. It consists of a 12-14 amino acid "core" or linker sequence that is present in all the isoforms and may be flanked by N-terminal and/or C-terminal segments. Each of the four CaM kinase genes can give rise to several isoforms by putative alternative splicing of the mRNA at the variable domain. Alternatively spliced isoforms of CaM kinase which contain different insertions in their variable domain include B and B' isoforms from rat brain (Bennett and Kennedy, 1987) , CaM kinase isoforms from Drosophila (Griffith and Greenspan 1993; Ohsako et al., 1993) y isoforms from human lymphocytes (Nghiem et al., 1993) and 6 isoforms from rat heart (Mayer et al., 1993; Schworer et al., 1993; Edman and Schulman, 1994) .
Are the (Y-, B-, y-. and S-CaM kinase isoforms functionally redundant or do they subserve specific physiological roles? Differences in kinetic properties, substrate specificity, subcellular localizations and/or expression patterns between the isoforms would argue for their functional significance. While little is known about unique kinetic properties or substrate specificity, several studies have described discrete expression patterns for each of the CaM kinase isoforms. (Y-and B-CaM kinase isoforms are neuron-specific and very abundant in the brain while y-and &CaM kinase isoforms are expressed at low levels in all tissues including brain (Tobimatsu and Fujisawa, 1989) . Furthermore, the expression of CX-and B-CaM kinase isoforms is not uniform across regions of the brain (Miller and Kennedy, 1985) . In the adult rat, a-CaM kinase is enriched in the forebrain, leading to a a:p subunit ratio of 3: 1. In the cerebellum, the level of a-CaM kinase expression is much lower resulting in a a:@ subunit ratio of 113-4. The y-and S-CaM kinase isoforms each exhibit a distinct regional distribution in rat brain (Sakagami and Kondo, 1993) . Other studies have shown that CaM kinase expression is developmentally regulated (Sahyoun et al., 1985; Kelly et al., 1987) . In the neonatal rat, P-CaM kinase is expressed at a higher level than cw-CaM kinase throughout the brain. However, while P-CaM kinase expression stays almost constant thereafter, the c&aM kinase level in the forebrain increases by approximately 10 fold during the second postnatal week. In addition, (Y-and p-Can/r kinase may also differ in their subcellular localization since mRNA for (Y-but not P-CaM kinase is found in the dendrites of hippocampal and cortical neurons (Burgin et al., 1990; Benson et al., 1992) .
Do alternatively spliced isoforms of CaM kinase have unique patterns of expression? The only alternatively spliced isoforms described thus far in the brain, /3-and P'-CaM kinase, seem to have identical expression patterns. In addition, alternatively spliced yp-and yc-CaM kinase isoforrns have similar expression patterns in non-neuronal tissues (Nghiem et al., 1993) . However, the splicing of non-neuronal S-CaM kinase mRNA is regulated in a tissue-specific manner (Schworer et al., 1993) . Furthermore, we have recently demonstrated differential intracellular localization for alternatively spliced S-CaM kinase isoforms from heart (Srinivasan et al., 1994) . Insertion of 11 amino acids in the variable domain of S,-CaM kinase generates a nuclear localization signal which targets the protein to the nucleus in transfected cardiac myocytes. In contrast, S,-and S,-CaM kinase isoforms which lack this particular insert are cytosolic. Benson et al. (1991 a) isolated a PCR fragment of monkey a-CaM kinase variable domain, termed I+~, which included a similar NLS-generating insert.
We describe here three new alternatively spliced isoforms of CaM kinase that were identified by RT-PCR using specific primers designed to span the variable domain of OL-or p-CaM kinase. Each of the isoforms, termed CY~-, p,-, and p',-CaM kinase, contains insertions or deletions in its variable domain. Interestingly, the expression patterns of the new isoforms are unique and differ from those of previously identified isoforms. While a-CaM kinase is expressed in throughout the brain, a,-CaM kinase can be detected only in the diencephalonlmidbrain regions. p,-and p',-CaM kinase are expressed earlier in development than pand p'-CaM kinase isoforms. In addition, we demonstrate that c+CaM kinase isoform is targeted to the nucleus in transfected cells. These observations provide the first example of differential expression of alternatively spliced isoforms of CaM kinase in the brain and support the idea that they are functionally significant.
Materials and Methods
Materials. Restriction enzymes and other DNA modifying enzymes were purchased from GIBCO BRL (Gaithersburg, MD) or New England BioLabs (Beverly, MA). Y-~~P-ATP (6000 Ci/mmol) was obtained from New England Nuclear (Boston, MA) and c@S-ATP was obtained from Amersham (Arlington Heights, IL). Rat forebrain CaM kinase was purified as described previously (Schulman, 1984) . Monoclonal antibodies for CaM kinase are anti CY-CaM kinase monoclonal antibody (CBa2) and anti p-C&l kinase monoclonal antibody (CBPI) (Baitinger et al., 1990 ) (also available from Gibco BRL). A second anti ol-CaM kinase monoclonal antibody (6G9) was purchased from Boebringer-Mannheim (Indianapolis, IN).
PCR primers
and PCR amplification.
We designed PCR primers to amplify across the variable domain of CY-or p-&M kinase. primer anneals to the calmodulin binding site (CBS) which is identical at the nucleotide level in both c1 and P-CaM kinase sequences. Therefore, this primer can be used to amplify cDNA of both isoforms. The 3' primers are specific for either (Y-or p-CaM kinase under our PCR conditions, since they correspond to a region with less sequence identity between (Y-and P-CaM kinase sequences differing in 7 out of 20 bases. Approximate positions of all PCR primers along CaM kinase sequences are summarized in Figure 1 . CBS (5'-GTCGGAATTCCATCCTCAC-CACTATGCTG-3') corresponds to nucleotides 905-924 in a-CaM kinase sequence (Lin et al., 1987; Bulleit et al., 1988) and 908-927 in p-CaM kinase sequence (Bennett and Kennedy, 1987) (733-758; l&U res&tion site as described for R4): R6 5'.CCGAACCTGCAGAATTCACGCCGA-GCCCAATCGCCAC!-3' '(:25-5; PstI and EcoRI restriction sites).
The PCR mix contained l/20 vol. from the reverse transcription reaction (see below) in 50 p,l of 30 mM potassium chloride, 10 mM TrisHCl, pH 8.4, 1.5 mM magnesium chloride, 0.001% (w/v) gelatin, 0.125 p,~ each dATP, dCTP, dGTP, and dTTP (Pharmacia, Piscataway, NJ), 0.5 pM each 5' and 3' primers, and 1 U of Taq DNA polymerase (Perkin-Elmer, Norwalk, CT). All amplifications were performed in a TwinBlock System thermal cycler (Ericomp Inc., San Diego, CA) involving an initial step of 5 min at 94°C followed by 25-35 cycles of 30 set at 94"C, 30 set at 55"C, and 1 min at 72"C, and ending with a 15 min incubation at 72°C. Samples of 8-12 ~1 from each PCR mixture were loaded on a 5% polyacrylamide gel and the products were visualized by ethidium bromide staining. In some experiments, the 5' primer was prelabeled with Y-'~P-ATP using T4 polynucleotide kinase. Labeled prim&s were separated from uninc&por&ed ATP on a G-25 Sephadex Quick Spin column (Boehrintrer-Mannheim.
Indianaoolis, IN) before use in PeR. When thk reaction contained a radioact&e primer; the gel was dried and autoradiographed.
RNA purz&ation and cDNA synthesis.
Brains of Sprague-Dawley rats at the indicated age were dissected to separate the cerebellum, diencephalon/midbrain, hippocampus, and frontal and occipital cortices. For isolation of caudate putamen, hypothalamus and thalamus, the brain of a 6 week old rat was sectioned using a sliding vibratome and 500 pm thick slices were carefully microdissected to obtain the desired region. Total RNA was isolated from the each brain sample using RNAzol reagent (Cinna/Biotecx Laboratories International, Friendswood, TX) according to the manufacturer's instructions. An additional step of digestion with RNase-free DNase (Boehringer-Mannheim, Indianapolis, IN) was performed to remove any residual DNA. The RNA samples were then phenol extracted and ethanol precipitated. For the preparation of first strand cDNA, 0.1-0.25 pg of total RNA was subjected to reverse transcription using random primers and Superscript enzyme (GIBCO BRL, Gaithersburg, MD). Primary cultures of hippocampal neurons were prepared and maintained essentially as described (Malgaroli and Tsien, 1992) . mRNA was extracted from the cells after S-10 d in culture using RNAzol reagent.
Subcloning.
a-CaM kinase clones: PCR products amplified with CBS and cwl primers from diencephalon/midbrain regions were cut with EcoRI and BamHI, inserted into appropriately digested pBluescript (Stratagene, La Jolla, CA) and sequenced. Longer fragments of a,-CaM kinase obtained by PCR amplification using CBS and 013 primers for the C-terminal half of the cDNA or al and (~2 primers for the N-terminal half (see Fig. l ), were digested and ligated into pBluescript. We verified by restriction digest which clones contained the 33 bp insertion and sequenced the variable domain of several clones.
B-CaM kinase clones: PCR products amplified with CBS and Bl primers from El8 cDNA were cut with EcoRI, subcloned into pBluescript, and sequenced. The N-terminal half of the mRNA was amplified using B2 and Bl primers and the C-terminal half using CBS and B3 primers (see Fig. 1 ). After subcloning, we sequenced the variable domain of several clone as well as 50-60% of the rest of the coding region.
Sequencing of all the double-stranded DNA constructs were carried out using T3 and T, oligonucleotides and Sequenase reagents (USB, Cleveland, OH) according to manufacturer's instructions.
Analysis
of the P-CUM kinase gene. Rat genomic DNA was used as a template for PCR amplification of the intron between exons X and IX and the intron between exons IX and VIII. CBS primer and a specific primer for exon IX (Bex9.1 5'-CGGAATTCATTGTGGCC-GGAGCGGTGGTC-3'; 957-978, EcoRI restriction site) were used to amplify a band of approximately 1 Kb that was subcloned into pBluescript. The genomic clones were sequence from the exons up to 200 nucleotides into the intron from each side. We used a different strategy to amplify the intron between exons IX and VIII, since this intron was very long. Therefore, we amplified only the exon/intron boundaries using a PCR primer that annealed to the exon (Bex9.3 5'-ACAGAATTCCGCTCCGGCCACAATGTC-3'; 962-980, EcoRI restriction site; BexS. 1 5'-GCAAGCTTGACTCCGTCTGCTITCTTG-3'; 1038-1059, Hind111 restriction site) and a PCR primer that annealed approximately 200 bp inside the intron (Bint9.4 or Bint8.3). The intronspecific primers were designed based on the partial sequence of this intron from mouse B-CaM kinase gene (K. Harbers, personal communication). A 210 bp fragment that spanned the exon/intron boundary at the end of exon IX was amplified by Bex9.3 and Bint9.4 PCR primers, and a 220 bp fragment that spanned the exon/intron boundary at the beginning of exon VIII was obtained using Pints.3 and Bex8.1 PCR primers. Both fragments were subcloned into pBluescript and sequenced.
Expression in COS-7 cells. The variable domain of o,-CaM kinase was amplified using a4 and a5 primers and inserted into o-CaM kinase-MS PCR 1000.12 vector via unique MluI and ScaI restriction sites (Srinivasan et al., 1994) . These sites were introduced into a-CaM kinase sequence by site directed mutagenesis. The o,-CaM kinase cDNA was subcloned into the EcoRI site of pSRo.BKS expression vector (Nghiem et al., 1993) . Full length cDNA for B-CaM kinase in pUC-18 was a gift from Dr. M. N. Waxham (University of Texas, Houston). We subcloned the EcoRI fragment from this construct into pSRa.BKS expression vector. In order to obtain full length cDNAs for Be-and B',-CaM kinase, the N-terminal half of B-CaM kinase was amplified from rat cerebellum using B6 and B5 primers and digested with PstI and BclI. The C-terminal half (including the variable domain) was amplified from El8 brain using B3 and B4 primers and digested with BclI and ApaI. . Structure and regional distribution of a-CaM kinase isoforms in rat brain. a, RT-PCR products that encompass the variable domain of o-&M kinase isoforms were amplified from the indicated brain regions and visualized by ethidium bromide staining of a 5% polyacrylamide gel. CBS and ol primers amplify a band of 301 bp for aCaM kinase (position marked by "a"). The intensity of the band in cerebellum is lower, reflecting lower level of a-CaM kinase mRNA expression in this region. An additional band of 334 bp (position marked by '&I') corresponding to a,-CaM kinase is detected in diencephalon/midbrain but not in other brain regions; b, Schematic of the variable domain of a-CaM kinase isoforms. PCR products corresponding to the variable domain of a-CaM kinase obtained from diencephaion/midbrain were subcloned and sequenced. In comparison to o-CaM kinase, o,-CaM kinase contains an 11 amino acid insertion at the C-terminal side of the linker sequence (lightly striped box).
vector. Full length clones corresponding to B,-and B',-CaM kinase were isolated and verified by sequencing of the variable domain.
COS-7 cells were transiently transfected with 15 pg of DNA per 10 cm plates by calcium phosphate precipitation essentially as described (Hanson et al., 1989) ; 70-80 hr after transfection cells were collected and disrupted by sonication with a water cup sonicator (Heat SystemsUltrasonics) in a lysis buffer containing 50 mu PIPES pH 7.0, 1 mM EGTA, 10% glycerol, 1 mM PMSE 10 kg/ml leupeptin, 10 pg/ml pepstatin, and 2 rrnvt DlT. Cell extracts were centrifuged at 12,000 X g for 20 min and the supematant was frozen at -80°C. Protein concentrations were routinely determined using Bradford assay (Bradford, 1976) with IgG as a standard.
Immunoprecipitation and protein gels.
Whole brain from El8 Sprague-Dawley rat was homogenize in 10 volumes of buffer A (40 mu Tris/I-ICl pH 7.6, 1 ITIM DTT, 1 mu EGTA, 1 mM EDTA, 1 mM PMSE 10 &ml leupeptin, and 10 kg/ml pep&&in). After centrifugation at 12,000 X g for 20 min at 4"C, the supematant was frozen at -80°C (cytosolic fraction). The pellet was resuspended in 10 volumes of buffer A containing 0.1% Triton X-100 (particulate fraction Residue 316 is changed from valine in the adult isoforms to alanine in the embryonic isoforms (underlined); c, immunoprecipitation of B-GM kinase isoforms from El8 B-CaM kinase was immunoprecipitated from cytosolic (cyt) or particulate (par) protein fractions using CBo2 and CBBl monoclonal antibodies, subjected to SDSwere carried out in RIPA buffer using CBo2 and CBBl monoclonal antibodies. Protein samples, either immunoprecipitated from El8 brain or COS-7 cell extracts, were subjected to electrophoresis on 8% SDSpolyacrylamide gels and transferred to nitrocellulose membranes. A calmodulin overlay assay using biotinylated calmodulin and enhanced chemiluminescense was performed as described previously (Nghiem et al., 1993) . CaM kinase activity assay. CaM kinase activity was assayed using a synthetic peptide substrate, autocamtide-2, with sequence based on an autophosphorylation site of CaM kinase (Hanson et al., 1989) . Standard assay mixes contained 50 mu PIPES pH 7.5, 10 mu magnesium acetate, 10 kg/ml calmodulin, 10 ~.LM autocamtide-2, 20 ~.LM yJ2P-ATP (1 Wmmol) and either 0.5 mu CaCl, for kinase activity or 0.5 mu EGTA as control. The reaction was started by the addition of protein extract to a final volume of 50 ~1 and incubated for 1 min at 30°C. Reactions were stopped with trichloroacetic acid, applied to phosphocellulose paper, washed, and measured for Cerenkov radiation. For detection of autophosphorylation, the reactions were incubated for 15 set at 30°C and StODDed bv the addition of SDS-arotein loading buffer.
Tran$ection of neuroblastoma C.&S and immu\ostaining. Human neuroblastoma cell line (SH-SYSY) was kindly provided by Dr. S. K. Fisher (University of Michigan, Ann Arbor) and cultured as described (Martin et al., 1993) . Calcium phosphate transfections and immunostaining of the transfected cells were carried out as described previously (Srinivasan et al., 1994) . Briefly, transfected neuroblastoma cells expressing o-or a,-CaM kinase were transferred onto glass coverslips and were fixed 48 hr posttransfection with 2% formaldehyde followed by methanol. The fixed cells were stained with CBa2 antibody and goat anti-mouse antibody coupled to rhodamine. The cells were viewed and photographed using Zeiss Axioplan Universal microscope equipped for fluorescence detection with 63X and 100X objectives.
Zmmunohistochemistry. Rats (Sprague-Dawley, 6 week old) were perfused with 4% paraformaldehyde + 0.1% gluteraldehyde in phosphate buffer. Brains were fixed overnight and incubated for an hour in 30% sucrose in 0.1 M phosphate buffer; 30 pm sections were permeabilized with 0.2% Triton-X100 in Tris-saline buffer for 15 min and then preincubated with 1% horse serum in Tris-saline for 1 hr. Incubations with CBa2 mAb (1: 1000) or 6G9 mAb (1:200) were carried out for 18 hr at 4°C followed by washing and incubation with biotinylated anti mouse IgG (Vector Laboratories, Burlingame, CA) for 2 hr. After washing and incubation with avidin-HRP for 1 hr. the slices were incubated in 0.02% 3,3' diaminobenzidine tetrahydrochloride in 50 mu Tris buffer and 0.003% hydrogen peroxide for 6-8 min. Finally, the sections were mounted onto slides, dehydrated, and photographed using a Leitz Dialux 20 microscope.
Results

a-CaM kinase isoforms in rat brain
Previous studies have suggested that isoforms of CaM kinase can be generated by putative alternative splicing at the variable domain of the protein. Therefore, we amplified fragments of OLor B-CaM kinase that include the variable domain using reverse transcription-polymerase chain reaction (RT-PCR). Specific PCR primers for ol-CaM kinase, CBS and al (Fig. l) , amplified a single product of the predicted size, 301 bp, from all brain regions (Fig. 2a ). An additional, larger product was amplified from diencephalon/midbrain. Sequence analysis of the two PCR products from diencephalommidbrain reveals that the 301 bp band is identical to nucleotides 905-l 189 of o-CaM kinase sequence (Lin et al., 1987) . The larger product contains additional 33 nucleotides which are inserted after position 984 (Fig. 2b) .
In order to determine whether this larger PCR fragment is part of a distinct CaM kinase isoform, we have amplified by PCR the entire coding region of a-CaM kinase from diencephalon/midbrain (see Materials and Methods). We confirmed by partial sequencing that the 33 bp insertion is present in the varit The Journal of Neuroscience, October 1995, 75(10) 6801 able domain of a full length message for CaM kinase. Since the new isoform, termed a,-CaM kinase, is identical to a-CaM kinase outside the variable domain, it is likely to be generated by alternative splicing of o-CaM kinase mRNA. The intensity of the PCR signal for c-r,-CaM kinase isoform in the diencephalon/midbrain suggests that this isoform accounts for a substantial amount of the total a-CaM kinase mRNA (Fig.  2a) . Furthermore, about half (7/12) of the subcloned PCR products from diencephalon/midbrain corresponded to a,-CaM kinase (data not shown), suggesting that there are roughly equal amounts of (Y-and c-u,-CaM kinase mRNA in the diencephalon/ midbrain. In contrast, the PCR signal of a,-CaM kinase in other regions of the brain was undetectable or very weak (Fig. 2a) . The expression of ala-CaM kinase appears to be regulated in a region-specific manner.
P-CUM kinase isoforms in rat brain
Based on the B-CaM kinase cDNA sequence, primers CBS and Bl ( Fig. 1) should amplify PCR products of 489 bp and 444 bp representing the variable domains of B-and B'-CaM kinase, respectively. The results of PCR amplification of B-CaM kinase from adult rat brain cDNA are shown in Figure 3a . The two largest bands correspond to B-CaM kinase, which is the major product, and B'-CaM kinase which is smaller and less intense. In addition to the B-and p'-CaM kinase bands there are two other minor, but distinct, smaller-sized products. When cDNA from embryonic day 18 (El@ is used as a template only the two smaller products are apparent (Fig. 3a) . These PCR products from E18, termed B,-and B',-CaM kinase because they are more predominantly expressed in embryonic brain, were subcloned and sequenced. The variable domain of B-CaM kinase consists of N-terminal and C-terminal sequences flanking a conserved linker. Unlike B-and B'-CaM kinase isoforms, both B,-and B',-CaM kinase isoforms lack 24 amino acids at the N-terminal segment of the variable domain (Fig. 3b) . In addition, the 15 amino acids that are absent in the C-terminal segment of the variable domain B'-CaM kinase are also absent in B',-CaM kinase isoform. Thus, B,-differs from B-CaM kinase and B',-differs from B'-CaM kinase by the lack of the same 24 amino acid segment. The deletion of this N-terminal segment changes amino acid 3 16 from valine to alanine without altering the reading frame of the message.
We next isolated full length cDNAs for B,-and B',-CaM kinase from El8 brain using RT-PCR. Analysis of the cDNA clones by restriction digestion and partial sequencing indicates that there is no difference between our clones and the B-CaM kinase sequence outside the variable domain (data not shown). However, all of our clones have an amino acid at position 522 that differs from the published sequence of B-CaM kinase (Bennett et al., 1987) . We find at this position a codon for arginine (CGC) whereas the published sequence of B-CaM kinase encodes for a proline (CCC). Furthermore, Mouse B-CaM kinase sequence encodes for Arg522 as well (Karls et al., 1992) . Alignment of the published OL-, y-, and 6-CaM kinase amino acid sequences also reveals an arginine at an equivalent position (Tobimatsu and Fujisawa, 1989) .
The abundance of mRNA for these new B-CaM kinase isopolyacrylamide gel electrophoresis and visualized using calmodulin overlay. Purified CaM kinase from adult forebrain (A) is used to mark the migration of B/B'-and o-&M kinase (60/59 and 54 kDa, respectively). . The structure of the rat @CaM kinase gene suggests that a shifted 3'-splice site is used to generate the embryonic isoforms of p-CaM kinase. a, The nucleotide sequence of @',-C&I kinase variable domain is shown, with sequences derived from exons boxed, based on the structure of the mouse p-CaM kinase gene (Karls et al., 1992) . Exon IX and exon VI are spliced out and three nucleotides, CAG, appear unexpectedly between exons X and VIII. b, Sequence analysis of the exonlintron boundaries from the end of exon X to the beginning of exon VIII of the rat P-CaM kinase gene reveals a repeat of the sequence CAG at the end of the intron between exons IX and VIII (underlined) . The suggested 3'-splice site for the embryonic isoforms is marked by an arrow. c, The alternative splicing that include or exclude exon IX in the mRNA involves a different 3'-splice site in front of exon VIII. As a result of choosing a shifted 3'-splice site when exon IX is excluded (in l3,-and l3',-CaM kinase isoforms), three base pairs (CAG) are included in the mRNA and encode for an additional alanine residue at junction of exons X and VIII.
forms in the embryonic brain is reflected in the expression of appropriately sized proteins. Calmodulin-binding proteins which match the calculated sizes of 57.9 kDa for B,-CaM kinase and 56.2 kDa for B',-CaM kinase are immunoprecipitated from El8 rat brain using cx-and B-CaM kinase specific monoclonal antibodies (Fig. 3~) . At this developmental stage, the embryonic B-CaM kinase isoforms seem to be more abundant than o-&M kinase.
Alternative splicing generates embryonic p-CaM kinase isoforms Genomic analysis has revealed that B-CaM kinase is encoded by a single copy gene (Bulleit et al., 1988) . Therefore, it is likely that the B,-and B',-isoforms are produced by alternative splicing of B-CaM kinase mRNA. The exomintron arrangement of the mouse B-CaM kinase gene establishes that the variable domain is constructed from four small exons of less than 75 bp each (Karls et al., 1992) . According to this structure of the gene, B'-and B',-CaM kinase lack exon VI, which accounts for the 15 amino acid deletion in their C-terminal segment (Fig. 3b) . Interestingly, the N-terminal deletion in both embryonic isoforms seems to be located on a single exon, designated exon IX.
However, our sequencing analysis found three additional nucleotides (CAG) that are inserted between exons X and VIII (Fig.  4a) . This observation was confirmed by analysis of at least three individual clones of B,-and B',-CaM kinase. In order to determine the source of these three nucleotides, we sequenced the relevant intromexon boundaries of rat B-CaM kinase gene based on the corresponding sequences from the mouse (K. Harbers, personal communication). We observed that the structure of the rat gene around exons X-VIII is identical to that of the mouse (Fig. 4b) . Moreover, a repeat of the sequence CAG is found at the end of the intron between exons IX and VIII. These data suggest that the addition of the three nucleotides in B,-and B',-CaM kinase sequences can be due to a slightly shifted 3'-splice site in front of exon VIII. During the processing of the mRNA for the B-and B'-CaM kinase isoforms the entire intron is left out. However, while generating the embryonic isoforms in which exon IX is spliced out, the splicing machinery seems to choose another 3'-splice site that results in the inclusion of the last three nucleotides of the intron in the message (Fig. 4~) . Thus, the additional three nucleotides in B,-and B',-CaM kinase appear to be derived from the intron and encode for an additional ala- . Developmental regulation of P-CaM kinase isoform expression. Autoradiograoh of RT-PCR Droducts that were obtained using 32P-labeled CBS and pi primers and equal amount of template derived-from Pl, P4, P13, P22, or adult (A) mRNA; 5 ~1 from each reaction was separated on a 5% polyacrylamide gel. The migration of the four p-CaM kinase isoforms is marked on the right. A similar pattern of expression is seen in the hippocampus and in the cerebral cortex, with a shift from embryonic to adult isoforms during the second postnatal week. The major P-GM kinase isoform in primary hippocampal culture (cd) is p',.
nine at the N-terminus of the linker sequence (underlined in Fig.  3b ).
/3-CaM kinase isoform expression is developmentally regulated Since we had found striking differences in the expression of B-GM kinase isoforms between embryonic and adult rat brain, we decided to look at their expression during development. Figure 5 shows the expression of P-CaM kinase isoforms in cerebral cortex and hippocampus at various postnatal developmental stages. p,-and B',-CaM kinase isoforms are expressed at high levels from birth until postnatal day 4 (P4). At P13 there is a large increase in the expression of the adult isoforms, p-and B'-CaM kinase, and a corresponding decrease in the expression of the embryonic isoforms. In the adult, only p-and B'-CaM kinase isoforms are detected. We later isolated RNA from P9 in order to narrow down the time window of the change in @C&l kinase isoform expression. The pattern of PCR bands in P9 is similar to the pattern seen on P4 (data not shown), suggesting that the change to the adult isoforms occurs between P9 and P13. We also looked at B-GM kinase isoforms in primary hippocampal cultures. Interestingly, after 10 d in culture p', is the predominant CaM kinase isoform (Fig. 5) . The developmental upregulation of ol-CaM kinase expression occurs primarily in the forebrain and hippocampus during the second postnatal week (Hanley et al., 1987) . Using c-w-CaM kinase specific PCR primers, we observed a large increase in mRNA levels for both OL-and a,-CaM kinase between P9-13 in the diencephalommidbrain (data not shown).
Functional expression of new (Y-and p-CaM kinase isoforms
We expressed the three new CaM kinase isoforms in order to determine whether they encode functional CaM kinases. CL~-, B,-, and B',-CaM kinase cDNAs were cloned into the pSRcl expression vector and transiently transfected into COS-7 cells. Extracts of transfected cells contained calmodulin-binding proteins of about 55.5 kDa, 58 kDa, and 56 kDa, compatible with the calculated sizes of cxg-, B,-, and B',-CaM kinase isoforms, respectively (Fig. 6a) .
We next tested the ability of (Ye-, B,-, and B',-CaM kinase to undergo autophosphorylation, a characteristic property of all known CaM kinase isoforms. Indeed, all three isoforms incorporated phosphate in a Ca2+/calmodulin-dependent manner (Fig.  6b) . The cytosolic fractions of transfected COS-7 cells were assayed for CaM kinase activity. All three isoforms show normal Ca2+/calmodulin-dependent phosphorylation of the specific CaM kinase substrate autocamtide-2 (Fig. 6~) . Thus, each of the new isoforms encodes the protein kinase activity characteristic of CaM kinase.
czB-CaM kinase is targeted to the nucleus
We have recently demonstrated a role for the variable domain in the subcellular targeting of CaM kinase isoforms (Srinivasan et al., 1994) . The variable domain of a,-CaM kinase contains a nuclear localization signal (NLS) which targets it to the nucleus in transfected cardiac myocytes. Sequence comparison reveals that oB-and 6,-G&l kinase isoforms share a similar NLS-generating segment in their variable domain. This C-terminal segment is KRKSSSSVQMM in 6,-CaM kinase and KRKSS-SSVQLM in a,-CaM kinase (Fig. 2b) . We therefore decided to study the subcellular targeting of transiently transfected a,-CaM kinase.
Human neuroblastoma cells transfected with either OL-or oBCaM kinase cDNA were analyzed by immunostaining with an ol-CaM kinase specific monoclonal antibody (CBo2). This antibody recognizes both (Y-and c-w,-CaM kinase on a Western blot (data not shown). a,-CaM kinase transfected cells exhibit bright nuclear staining with no detectable cytoplasmic signal, indicating that c-w,-CaM kinase is specifically targeted to the nucleus (Fig. 7) . In contrast, o-CaM kinase is excluded from the nucleus and exhibits an exclusively cytoplasmic pattern of staining. Since ol,-CaM kinase differs from aCaM kinase by the 11 amino acids insert (Fig. 2b) , these results suggest that the variable domain of a,-CaM kinase is responsible for targeting this isoform to the nucleus. It is important to note that the transfected cells were not stimulated in any way prior to fixation and immunostaining. Therefore, our results also imply that the localization of cr,-CaM kinase to nucleus may not require activation by Ca2+/calmodulin.
Is IX,-CaM kinase localized to neuronal nuclei in the brain? We used a-CaM kinase antibodies to examine the intracellular distribution of c-u-CaM kinase isoforms in the diencephalommidbrain structures, where both (Y-and ol,-CaM kinase isoforms are expressed, and a forebrain structure, where only or-CaM kinase is expressed (Fig. Za) . In hypothalamic and thalamic neurons the immunostaining is both cytoplasmic and nuclear but in the caudate putamen the immunostaining is only cytoplasmic (Fig.  8a-c) . RT-PCR analysis demonstrates that a,-CaM kinase a--b A pe P'e % mock -+-+-+-+-+ mRNA is almost equally abundant as aCaM kinase mRNA in the thalamus and hypothalamus whereas only a-CaM kinase mRNA is present in the caudate putamen (Fig. 8d) . Taken together, the immunostaining and the RT-PCR analysis show that only thalamic and hypothalamic neurons which express a,-CaM kinase isoform exhibit nuclear staining. Therefore, or,-CaM kinase isoform seems to be targeted to the nucleus in neurons.
Discussion
In this report we describe the isolation and functional expression of three new CaM kinase isoforms from rat brain, termed c+,-, p,-, and p',-CaM kinase. These isoforms are probably generated by alternative splicing of 01-and P-CaM kinase mRNAs. (YeCaM kinase contains an 11 amino acid insertion at the C-terminal segment of the variable domain. The P-CaM kinase isoforms, p,-and p',-CaM kinase, both lack 24 amino acids which form the N-terminal segment in p-and p'-CaM kinase variable domains. The P'&-CaM kinase, like p'-CaM kinase, lacks 15 amino acids at the C-terminal side of the linker sequence. Thus, the P-CaM kinase isoform has a large variable domain containing exons IX-VI (Karls et al., 1992) , p,-and p',-CaM kinase isoforms lack exon IX (24 amino acids), and p'-and p',-CaM kinase isoforms lack exon VI (15 amino acids) due to alternative splicing. The existence of additional p-CaM kinase isoforms was suggested by Bulleit et al. (1988) . In performing an Sl protection assay using a probe to the variable domain they detected protected fragments that did not correspond to p-and p'-CaM kinase and commented that this finding could be accounted for by an additional deletion.
Generation of the p,-and p',-CaM kinase isoforms involves a small shift in the 3'-splice site, resulting in two alanine residues that are encoded in part by nucleotides derived from the intron. Several other known genes contain two adjacent potential 3'-splice site at the intron/exon boundary that are utilize to include or exclude three base pairs (CAG) in the mRNA (Maurer et al., 1981; Shelness and Williams, 1984; Cook et al., 1985; Sun and Baltimore, 1991; Manrow and Berger, 1993) . The effect of the additional alanine on p,-and p',-CaM kinase proteins remains unclear, although in all the other cases reported no particular function is associated with the choice of the 3'-splice site.
The newly isolated CaM kinase isoforms have different expression patterns from the previously characterized isoforms. a-Q&l kinase is the predominant isoform in the brain and has a broad regional distribution with particularly high levels of expression in the hippocampus and cortex. By contrast, the expression of a,-CaM kinase mRNA in rat brain is restricted to the diencephalon/midbrain with little or no mRNA in the hippocampus and the cortex (Fig. 2b) . Previous studies surveying ol-CaM kinase immunoreactive or autophosphorylated protein noted that in the diencephalon/midbrain, but not in other brain regions, ol-CaM kinase migrated as a doublet on SDS-polyacrylamide gels with a new band of slightly lower mobility (Walaas et al., 1983; Erondu and Kennedy, 1985) . This band is probably a,-CaM kinase and appears to be a significant fraction of the CaM kinase protein in the diencephalon/midbrain. A fragment of a,-CaM kinase was originally amplified as a PCR product from monkey frontal cortex mRNA (Benson et al., 1991a) . In that study, 2 of 8 cDNA clones obtained by PCR amplification across the variable domain of o-CaM kinase were of ~~33, the fragment with a 33 bp insert relative to o-CaM kinase, suggesting that a,-CaM kinase is likely to be a significant form of cortical kinase in primates. By contrast, we could not detect this isoform in rat frontal cortex (Fig. 2~ ). This apparent speciesspecific difference in cx,-CaM kinase distribution may be useful in identifying the possible unique function of o+CaM kinase.
We have demonstrated that the alternative splicing of B-CaM kinase mRNA is developmentally regulated. From El8 through the first postnatal week, B,-and B',-CaM kinase are the most highly expressed isoforms. The expression of the adult isoforms, B-and B'-CaM kinase, is upregulated during the second postnatal week while the mRNAs for B,-and B',-CaM kinase almost disappear by P13 and beyond. There appears to be a developmental control of the splicing of exon IX, which is missing in both embryonic isoforms and present in both adult isoforms. Several studies have addressed the expression of the CaM kinase isoforms during development using isoform-specific antibodies (Sahyoun et al., 1985; Weinberger and Rostas, 1986) . In neonate brain, B-GM kinase protein is expressed at a higher level than o-CaM kinase. This level of B-G&I kinase expression does not change through subsequent development and aging. On the other hand, ol-CaM kinase protein is expressed at low levels at birth and increases sharply between P5 and PlO. However, the antibodies used could not distinguish between B-and B'-CaM kinase isoforms and therefore probably cannot discriminate between these and the embryonic isoforms. In situ hybridization and Northern analysis studies were consistent with the immunodetection data (Hanley et al., 1987; Burgin et al., 1990) . However, the specific probes used in these studies did not discriminate between the four B-CaM kinase isoforms that we now know exist. For example, Burgin et al. (1990) used a probe which Figure 8 . Intracellular localization of o-&M kinase immunostaining in several regions of rat brain is correlated with the expression of a-CaM kinase isoforms. Immunostaining with a-CaM kinase specific monoclonal antibodies (CBo2 or 6G9) of the caudate putamen (a), thalamus (b), and hypothalamus (c) detects nuclear staining only in thalamic and hypothalamic neurons. Scale bar, 55 pm. d, Ethidium bromide staining of RT-PCR products obtained using templates derived from the caudate putamen, thalamus or hypothalamus and a-CaM kinase specific primers (CBS and al). A larger band which corresponds to a,-CaM kinase is detected in the hypothalamus and thalamus but not in the caudate putamen. The control reaction did not contain template.
corresponds to a segment of the variable domain (base pairs 1090-l 128) that is common to all P-CaM kinase isoforms. Similarly, Karls et al (1992) amplified a PCR fragment in the association domain (base pairs 1259-1663) present in all P-CaM kinase isoforms.
Our data clearly indicate that although the expression of the sum total of @CaM kinase isoforms may not change during development, there appears to be a switch from the embryonic isoforms to the adult isoforms (Figs. 3~2, 5) . The developmental switch in the expression of P-CaM kinase isoforms and the increase in a-CaM kinase expression occur at approximately the same period, between P9 and P13. The second postnatal week is considered to be a phase of ongoing synaptogenesis in rat brain development. It is possible that changes in the expression of CaM kinase isoforms play a role in the process of neuronal maturation.
What is the physiological significance of the multiple isoforms of (Y-and P-CaM kinase? The variable domain resides between the regulatory and association domains of the enzyme. An electron microscopy study of CaM kinase holoenzyme structure has suggested a planar, flower with petal-like arrangement of the subunits (Kanaseki et al., 1991) . According to this model, residues 3 17-328 in the a-CaM kinase variable domain form a tether that links the globular catalytic/regulatory particle at the periphery to a central, large globular particle composed of all the association domains. In fact, the residues in @CaM kinase corresponding to this putative linker are encoded by a separate exon (exon VIII). In such a structure, the N-terminal segment of the variable domain (exon IX) will reside in the outer particle and the C-terminal segment (exons VI and VII) in the inner particle. Sequences derived from exon IX may therefore affect the catalytic functions such as calmodulin affinity whereas exon VI and VIII derived sequences may affect the assembly of the kinase into a multimer or targeting to intracellular sites. Sequences spliced in at either end may introduce phosphorylation sites for modulators of these functions.
Autophosphorylation is an important mechanism for the modulation of CaM kinase activity. The autonomy site (Thrzs7 in B-CaM kinase sequence) is crucial for Ca2+-independent activity of CaM kinase (Fong et al., 1989; Hanson et al., 1989) . Other sites of autophosphorylation inhibit CaM kinase activity after dissociation of calmodulin (Patton et al., 1990; Hanson and Schulman, 1992b) . It is interesting to note that exon IX contains a potential autophosphorylation sites (R-X-X-S/T).
However, phosphopeptide mapping of B-CaM kinase subsequent to Ca2+/ calmodulin-stimulated autophosphorylation identified a nonconsensus site on exon VI (Miller et al., 1988) . Although the potential site on exon IX was not found to be phosphorylated, this exon is particularly rich in serine and threonine residues (8 out of 24 amino acids) and some of these may be phosphorylated by other protein kinases or autophosphorylated under other conditions. The B-CaM kinase has a higher affinity for calmodulin than the cw-CaM kinase (Miller and Kennedy, 1985; Yamauchi et al., 1989) . The calmodulin affinity of the embryonic B-CaM kinase isoforms may be effected by the deletions in the variable domain.
We have demonstrated that ol,-CaM kinase isoform is targeted to the nucleus in transfected cells. a,-CaM kinase contains a consensus NLS, KKRK (Fig. 2b) which has been reported to target proteins to the nucleus (reviewed in Garcia-Bustos et al., 1991) . Two other CaM kinase isoforms, yA and 6,, have NLSgenerating inserts in the C-terminal segment of their variable domains. We have recently shown that the KKRK sequence is critical for targeting S,-CaM kinase isoform to the nucleus (Srinivasan et al., 1994) . These results indicate that a sequence in the C-terminal segment of the variable domain targets CaM kinase to the nucleus. It is possible that different insertions in the C-terminal segment of the variable domains could target other CaM kinase isoforms to distinct non-nuclear sites.
Previous surveys of ol-CaM kinase immunohistochemistry did not detect nuclear staining (Erondu and Kennedy, 1985; Benson et al., 1991b) . Nuclear CaM kinase activity has been reported by others, although the corresponding isoform was not identified and the forebrain activity was probably cytoskeletal rather than nuclear since there is little or no nuclear CaM kinase in this region (Sahyoun et al., 1984; Ohta et al., 1990) . We show here that there is a strong correlation between nuclear staining with cu-CaM kinase antibody the regional expression of a,-CaM kinase isoform in rat brain. In caudate putamen neurons that express only a-CaM kinase isoforms the immunostaining is cytoplasmic. In thalamic and hypothalamic neurons that express both (Y-and a,-CaM kinase isoforms the immunostaining is cytoplasmic and nuclear. We have previously shown that cells cotransfected with a nuclear isoform and a cytosolic isoform in a 1: 1 ratio exhibit both nuclear and cytosolic targeting of CaM kinase (Srinivasan et al., 1994) . Thus, the observed intracellular distribution of (Y-and a,-CaM kinase isoforms in the thalamus and the hypothalamus (Fig. 8b-d) is consistent with the localization pattern in transfected cells.
CaM kinase has been implicated in several nuclear functions including nuclear envelope breakdown, regulation of cell cycle, and gene expression (Baitinger et al., 1990; Sheng et al., 1991; Planas-Silva and Means, 1992) . A recent study has found that a-CaM kinase in the nucleus phosphorylates CREB at two sites, one of which blocks transcriptional activation of CREB by CAMP or calcium (Sun et al., 1994) . This suggests that the amount of au,-CaM kinase in the nucleus could determine the effectiveness of other signals in CREB-mediated transcription. CREB phosphorylation in response to elevated CAMP is known to be important for the induction of various neuropeptides in the hypothalamus. Nuclear a,-CaM kinase in hypothalamic neurons may provide an antagonistic pathway. It will be interesting to investigate the precise distribution of a,-CaM kinase in the hypothalamic and thalamic nuclei by in situ hybridization and assess the specific nuclear functions that may be modulated by the kinase in these cells. Previous studies addressing the role of CaM kinase in gene expression utilized a truncated form of (Y-CaM kinase lacking the association domain. This form is monomeric and not excluded from the nucleus. Our study demonstrates that there is an isoform of CaM kinase specifically designed to enter the nucleus and mediate neuronal functions.
